Tenon Medical Shares Rise 42% After Passing FDA Inspection

By Chris Wack

Tenon Medical shares were up 42% at $1.21 after the company passed an FDA Level 2 inspection.

The stock hit its 52-week low of 77 cents on Wednesday, and is down 94% in the past 12 months.

The patient-care company said the U.S. Food and Drug Administration concluded a full Quality System Inspection Technique Level 2 inspection, to assess a medical device manufacturer's compliance with the Quality System Requirements regulations.

At the conclusion of the inspection on Wednesday, the FDA investigator determined the meeting was completed with no observations or objectionable conditions identified. A final report will be issued to the company over the coming weeks.

Write to Chris Wack at [e-mail]

(END) Dow Jones Newswires

11-03-23 1104ET